News
Nongshim RedForce's slide continues. Nongshim lost 0–2 to Gen.G in a Round 4 matchup of the 2025 LCK at LoL Park in Jonggak, ...
Round four of the LCK 2025 will see T1 face Hanwha Life Esports for a chance to tie the Group Stage record. The former ...
T1 support Ryu “Keria” Min-seok attended the post-match interview after the team swept KT Rolster 2–0 in Round 4 of the 2025 ...
Ahead of the League of Legends Worlds 2025, we break down each region and present the teams most likely to make it to the LoL showpiece event.
The LCK 2025 Season features T1 vs KT Rolster on August 13, 2025. The former's decisive victory over Nongshim last week ...
- Katiso “KT” Molefe, accused of masterminding DJ Sumbody’s murder, was arrested at his Sandton home, where the PA’s Kenny Kunene was present. - Kunene claims he was there with a journalist to arrange ...
KT Plus 150: 'Super influencers' join judges' panel, see full list here Three new expert judges join the panel as the hunt goes on for the next 150 trailblazers in the UAE ...
South Korean telecommunications giant KT said Monday it is joining hands with Nokia Bell Labs Core Research to advance research and commercialization of semantic communication technology for the ...
KT remained the media's go-to guy. He was always fair and honest, and more times than not could fix an issue -- or knew someone who could. His resume is a who's who in college athletics.
The chief of KT Studio Genie ('Extraordinary Attorney Woo') reckons they are the only Korean production company thinking seriously about micro-dramas.
Kymera on Wednesday said Sanofi won't advance KT-474, which in late 2023 entered Phase 2 studies trials in patients with the inflammatory skin diseases hidradenitis suppurativa and atopic dermatitis.
Sanofi will advance Kymera's KT-485 into clinical trials while discontinuing KT-474, offering significant collaboration milestones.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results